(VIANEWS) – BanColombia S.A. (CIB), Edwards Lifesciences (EW), Alaska Air Group (ALK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. BanColombia S.A. (CIB)
53.1% sales growth and 15.73% return on equity
Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other. It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; financial support to real estate developers and mortgages for individuals and companies; and financial and operating leasing services. The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products. In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; and online and computer banking services. Further, the company provides investment banking services comprising project and acquisition finance, debt and equity capital markets, principal investments, M&A, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment trust, custody, and corporate trust; and digital banking platform, transportation, securities brokerage, maintenance and remodeling, advertising and marketing, and outsourcing services, as well as credit cards. As of December 31, 2020, it operated 1,057 branches; 18,631 banking correspondents; 535 PAMs; 215 kiosks in El Salvador and 137 in Colombia; and 6,124 automatic teller machines. Bancolombia S.A. was incorporated in 1945 and is headquartered in MedellÃn, Colombia.
Earnings Per Share
As for profitability, BanColombia S.A. has a trailing twelve months EPS of $6.49.
PE Ratio
BanColombia S.A. has a trailing twelve months price to earnings ratio of 5.25. Meaning, the purchaser of the share is investing $5.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.73%.
Volume
Today’s last reported volume for BanColombia S.A. is 209745 which is 31.07% below its average volume of 304309.
2. Edwards Lifesciences (EW)
9.6% sales growth and 21.28% return on equity
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.3.
PE Ratio
Edwards Lifesciences has a trailing twelve months price to earnings ratio of 39.25. Meaning, the purchaser of the share is investing $39.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.28%.
3. Alaska Air Group (ALK)
5.7% sales growth and 6.39% return on equity
Alaska Air Group, Inc., through its subsidiaries, provides passenger and cargo air transportation services. The company operates through three segments: Mainline, Regional, and Horizon. It has a network of approximately 1,300 daily flights to 115 destinations across the United States, Mexico, Canada, and Costa Rica. The company was founded in 1932 and is based in Seattle, Washington.
Earnings Per Share
As for profitability, Alaska Air Group has a trailing twelve months EPS of $1.89.
PE Ratio
Alaska Air Group has a trailing twelve months price to earnings ratio of 22.9. Meaning, the purchaser of the share is investing $22.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.39%.
Volume
Today’s last reported volume for Alaska Air Group is 1144770 which is 49.07% below its average volume of 2247960.
Yearly Top and Bottom Value
Alaska Air Group’s stock is valued at $43.29 at 11:22 EST, way under its 52-week high of $57.18 and way above its 52-week low of $30.75.
Moving Average
Alaska Air Group’s value is higher than its 50-day moving average of $41.06 and way above its 200-day moving average of $38.88.
4. Primerica (PRI)
5.6% sales growth and 28.56% return on equity
Primerica, Inc., together with its subsidiaries, provides financial products to middle income households in the United States and Canada. The company operates in three segments: Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. It underwrites individual term life insurance products. The company also provides mutual funds and various retirement plans, managed investments, variable and fixed annuities, fixed indexed annuities, and segregated funds. In addition, it offers auto and homeowners' insurance, home automation solutions, and mortgage loans; ID theft defense services; and insurance products, including supplemental medical and dental, accidental death, and disability for small businesses. Further, the company provides prepaid legal services that assist subscribers with legal matters, such as drafting wills, living wills and powers of attorney, trial defense, and motor vehicle-related matters. It distributes and sells its products through licensed sales representatives. Primerica, Inc. was founded in 1927 and is headquartered in Duluth, Georgia.
Earnings Per Share
As for profitability, Primerica has a trailing twelve months EPS of $16.4.
PE Ratio
Primerica has a trailing twelve months price to earnings ratio of 13.64. Meaning, the purchaser of the share is investing $13.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.56%.
Moving Average
Primerica’s worth is below its 50-day moving average of $234.98 and higher than its 200-day moving average of $217.41.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.4%, now sitting on 2.93B for the twelve trailing months.
Sales Growth
Primerica’s sales growth is 5.3% for the ongoing quarter and 5.6% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 20, 2024, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 1.34%.
